Point-of-care viral load tests to detect high HIV viral load in people living with HIV/AIDS attending health facilities.

Background: Viral load (VL) testing in people living with HIV (PLHIV) helps to monitor antiretroviral therapy (ART). VL is still largely tested using central laboratory-based platforms, which have long test turnaround times and involve sophisticated equipment. VL tests with point-of-care (POC) platforms capable of being used near the patient are potentially easy to use, give quick results, are cost-effective, and could replace central or reference VL testing platforms.

Comparison of the costs of HPV testing through community health campaigns versus home-based testing in rural Western Kenya: a microcosting study.

Objectives: To estimate the cost of human papillomavirus (HPV)-based screening through community health campaigns (CHCs) and home-based testing.

Setting: CHCs and home-based testing in six communities in rural Western Kenya.

Participants: CHCs and home-based screening reached 2297 and 1002 women aged 25-65 years, respectively.